201 related articles for article (PubMed ID: 31446047)
21. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
22. Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB/c mice.
Zhang JX; Zha WS; Ye LP; Wang F; Wang H; Shen T; Wu CH; Zhu QX
J Appl Toxicol; 2016 Feb; 36(2):271-84. PubMed ID: 26095957
[TBL] [Abstract][Full Text] [Related]
23. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
Chen J; Sun ZH; Chen LY; Xu F; Zhao YP; Li GQ; Tang M; Li Y; Zheng QY; Wang SF; Yang XH; Wu YZ; Xu GL
Aging (Albany NY); 2020 Jul; 12(14):14285-14299. PubMed ID: 32669478
[TBL] [Abstract][Full Text] [Related]
24. Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
Zhu M; He X; Wang XH; Qiu W; Xing W; Guo W; An TC; Ao LQ; Hu XT; Li Z; Liu XP; Xiao N; Yu J; Huang H; Xu X
Diabetologia; 2017 Sep; 60(9):1822-1833. PubMed ID: 28577176
[TBL] [Abstract][Full Text] [Related]
25. Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway.
Cao Q; McIsaac SM; Stadnyk AW
Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1731-40. PubMed ID: 22496247
[TBL] [Abstract][Full Text] [Related]
26. Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.
Kalbasi Anaraki P; Patecki M; Larmann J; Tkachuk S; Jurk K; Haller H; Theilmeier G; Dumler I
Stem Cells Dev; 2014 Feb; 23(4):352-62. PubMed ID: 24192237
[TBL] [Abstract][Full Text] [Related]
27. The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered
Sahoo AR; Mishra R; Rana S
Sci Rep; 2018 Feb; 8(1):2955. PubMed ID: 29440703
[TBL] [Abstract][Full Text] [Related]
28. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
29. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
30. Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.
Bujko K; Rzeszotek S; Hoehlig K; Yan J; Vater A; Ratajczak MZ
Stem Cell Rev Rep; 2017 Dec; 13(6):793-800. PubMed ID: 28918528
[TBL] [Abstract][Full Text] [Related]
31. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
32. Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
Qing X; Koo GC; Salmon JE
Eur J Immunol; 2012 Jul; 42(7):1723-34. PubMed ID: 22535677
[TBL] [Abstract][Full Text] [Related]
33. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
34. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
[TBL] [Abstract][Full Text] [Related]
35. Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.
Xu Y; Tian Z; Xie P
Mol Med Rep; 2014 Oct; 10(4):1786-92. PubMed ID: 25050483
[TBL] [Abstract][Full Text] [Related]
36. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
[TBL] [Abstract][Full Text] [Related]
37. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
38. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
[TBL] [Abstract][Full Text] [Related]
39. Function, structure and therapeutic potential of complement C5a receptors.
Monk PN; Scola AM; Madala P; Fairlie DP
Br J Pharmacol; 2007 Oct; 152(4):429-48. PubMed ID: 17603557
[TBL] [Abstract][Full Text] [Related]
40. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
